Iconeus was a proud sponsor of this eminent scientific conference in Barcelona, co-chaired by one of our founders and Senior Scientific Advisors, Prof. Zsolt Lenkei. Gathering together, at a stunning location overlooking the Mediterranean Sea next to Barcelona, top-level scientists from around the world, including the key-notre speaker Thomas Sudhof from Stanford University, winner of the 2013 Nobel Prize in Physiology or Medicine, the major objective of this Gordon Research Conference was to showcase unpublished research data addressing the burning questions of cannabinoid research thereby stimulating the life science community to focus on solving these pending challenges: What is the molecular logic behind canonical and non-canonical cannabinoid receptor signaling distinguishing them from classical GPCR activation patterns? What are the molecular underpinnings of intracellular versus intercellular forms of endocannabinoid signaling? Why there are different types of endocannabinoids and what is the division of labor between these lipid messengers in synaptic and extrasynaptic signaling? How the different forms of endocannabinoid-mediated plasticity are integrated into specific brain circuit functions in the developing and adult brain? How emerging knowledge on aberrant forms of endocannabinoid signaling leads to the better mechanistic understanding of the pathogenesis of many neurological and psychiatric brain disorders? Finally, how medical marijuana use and how recreational cannabis abuse lead to therapeutic benefits or to neuropsychiatric diseases, respectively?
By allowing imaging of cannabinoid effects on brain activation and connectivity with unprecedented resolution and ease-of-use, Iconeus technology has bright future in neuropharmacology.